Zobrazeno 1 - 8 of 8 pro vyhledávání: '"André J. Vlot"'
1
Factor VIII inhibitor in a patient with mild haemophilia A and an Asn618 →Ser mutation responsive to immune tolerance induction and cyclophosphamide
Autor: Jan Voorberg, H. Marijke van den Berg, S. Wittebol, André J. Vlot, Paul F. W. Strengers, Ellen A. M. Turenhout, Eveline P. Mauser-Bunschoten
Publikováno v: British Journal of Haematology. 117:136-140
We describe a patient with mild haemophilia A (original value of factor VIII activity 0.30 U/ml) who developed an inhibitor (36.1 Bethesda U/ml) which cross-reacted with his endogenous factor VIII. This caused a decline in basal factor VIII level ( S
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::07443facbe3b97beed9ee2e57796b380
https://doi.org/10.1046/j.1365-2141.2002.03383.x
Zobrazit plný text záznamu
2
Factor VIII and von Willebrand Factor
Autor: Jan J. Sixma, SJ Koppelman, André J. Vlot, Bonno N. Bouma
Publikováno v: Thrombosis and Haemostasis. 79:456-465
IntroducationFactor VIII and von Willebrand factor are plasma glycoproteins whose deficiency or structural defects cause hemophilia A and von Willebrand disease, respectively (1). These diseases are the most common inherited bleeding disorders of man
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::aaf6dc5ba65f83fbd09679cfdd3bde87
https://doi.org/10.1055/s-0037-1614927
Zobrazit plný text záznamu
3
Requirements of von Willebrand factor to protect factor VIII from inactivation by activated protein C
Autor: C. Damas, SJ Koppelman, M. E. Schiphorst, Robert J. Wise, H. Lankhof, M. Van Hoeij, B. N. Bouma, J. J. Sixma, André J. Vlot, Tom Vink
Publikováno v: Blood. 87:2292-2300
The interaction of factor VIII with von Willebrand factor (vWF) was investigated on a quantitative and qualitative level. Binding characteristics were determined using a solid phase binding assay and protection of factor VIII by vWF from inactivation
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::178f761d16fbcf9b488c4fa2e60845d7
https://doi.org/10.1182/blood.v87.6.2292.bloodjournal8762292
Zobrazit plný text záznamu
4
Kinetics of factor VIII-von Willebrand factor association
Autor: GM Willems, André J. Vlot, B. N. Bouma, Joost C. M. Meijers, H. Van Den Berg, C Dama, J. J. Sixma, SJ Koppelman
Publikováno v: Blood. 87:1809-1816
The binding of factor VIII to von Willebrand factor (vWF) is essential for the protection of factor VIII against proteolytic degradation in plasma. We have characterized the binding kinetics of human factor VIII with vWF using a centrifugation bindin
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::44d3b18f61899f2b96e8c1f999a8f81b
https://doi.org/10.1182/blood.v87.5.1809.1809
Zobrazit plný text záznamu
7
Factor VIII inhibitor in a patient with mild haemophilia A and an Asn618--Ser mutation responsive to immune tolerance induction and cyclophosphamide
Autor: André J, Vlot, Shulamiet, Wittebol, Paul F W, Strengers, Ellen A M, Turenhout, Jan, Voorberg, H Marijke, van den Berg, Eveline P, Mauser-Bunschoten
Publikováno v: British journal of haematology. 117(1)
We describe a patient with mild haemophilia A (original value of factor VIII activity 0.30 U/ml) who developed an inhibitor (36.1 Bethesda U/ml) which cross-reacted with his endogenous factor VIII. This caused a decline in basal factor VIII level (0.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::285a8aab991f86725aa7845501e558f7
https://pubmed.ncbi.nlm.nih.gov/11918545
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje